Trial now
POLAND

A Benchmark Rate at 2% Would 'Not Be Excessive'

GILTS

Yield curve shifts higher with 5s30s flattening

EUROZONE ISSUANCE

Austria lowers 2021 funding target

Merck&Co Market News

Sign up now for free access to this content.

Please enter your details below and select your areas of interest.

Latest on Merck&Co Market News

Market News Resources